GSK in Barclays deal
September 30, 2013Sales and Marketing GSK, Zambia, barclays, csr
GlaxoSmithKline has signed a deal with banking giant Barclays in a bid to improve private sector health in Zambia, thus …
Cancer Drugs Fund to run until 2016
September 30, 2013Research and Development, Sales and Marketing CDF, Cameron, NHS, NICE, VBP
England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …
InVentiv Health makes strategic appointments
September 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentiv Health
Healthcare consultancy firm InVentiv Health has created two new positions
 to lead its growing business opportunities in Europe and Asia. …
The future of data disclosure in Europe
September 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, GSK, transparency
The debate of clinical trial transparency has at times appeared a peculiarly British issue, but plans are afoot in Europe …
Boehringer cuts ribbon on €70m addition to Shanghai plant
September 27, 2013Manufacturing and Production, Sales and Marketing Boehringer, China, Shanghai
Boehringer Ingelheim has officially opened the €70 million expansion of its facility in Zhangjiang, China, that is designed to triple …
NICE recommends ovarian cancer drug Caelyx
September 27, 2013Sales and Marketing NICE, Yondelis, ovarian cancer
Cancer Drugs Fund to stay, government to announce
September 27, 2013Medical Communications, Sales and Marketing CDF, Cameron, NHS, NICE, VBP, prime minister
The UK’s prime minister is set to announce that the controversial Cancer Drugs Fund will remain in place after March …
PM Society’s digital award winners announced
September 27, 2013Medical Communications, Sales and Marketing digital awards, pm society
The independent comms agency Ruder Finn and creative marketing shop Digitas Healthcare won most recognition at the PM Society Digital …
Novartis ‘sorry’ for Diovan data
September 27, 2013Sales and Marketing Japan, Novartis, diovan data
Novartis has apologised to patients in Japan over the alleged manipulation of data in five trials of its blockbuster blood …
Brown Rudnick appoints partner
September 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brown rudnick
Sophie McGrath has joined law firm Brown Rudnick as a partner and is to focus on life sciences at the …
Bayer slammed for ‘nightcaps’
September 26, 2013Medical Communications, Sales and Marketing ABPI, Bayer, PMCPA
Bayer has come under fire from the PMCPA for providing late-night drinks to delegates at a conference in Amsterdam, exceeding …
Amgen to open Chinese R&D centre
September 26, 2013Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang
Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …
Merck Serono won’t give up on cancer vaccine
September 26, 2013Sales and Marketing Merck, Merck Serono, Stimuvax
Merck Serono’s once failed lung cancer vaccine treatment Stimuvax has been given a second chance as the German firm begins …
Circassia appoints new chairman from Biogen Idec
September 26, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Circassia, granata
Speciality biopharma firm Circassia has appointed Dr Francesco Granata as its non-executive chairman. Granata is executive in Residence at Warburg …
Roche’s new Herceptin jab approved by NHS
September 25, 2013Sales and Marketing Herceptin, Kadcyla, Roche, breast cancer
MSD’s sugammadex knocked back by FDA – again
September 25, 2013Research and Development, Sales and Marketing FDA, MSD, Merck, Sugammedex
NICE: final ‘no’ for Xalkori
September 25, 2013Sales and Marketing NICE, NSCLC, Pfizer, Xalkori
Pfizer’s worst fears have been confirmed today by NICE, which has rejected its new lung cancer drug Xalkori because of …
Zaicom appoints chief operating officer
September 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Zaicom, cossins
Zaicom International which focusses on comms, market research and regulatory solutions in healthcare has appointed Stuart Cossins as its chief …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
